AJANTPHARMBSEAjanta Pharma Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 3 Jul, 2026 · 11:12 IST

Disclosure of pledge of 66.32 lakh shares (5.31%) of Ajanta Pharma

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.0%Reaction day
₹3340.00
prior close
₹3378.00
announcement price
In-mkt
timing
Nifty Midcap 150market-0.2%+0.2% vs market
Pharmaceuticals peers, median of 165sector+0.2%-0.2% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Midcap 150 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.0
10m
+0.0
15m
+0.1
30m
-0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.0-0.2+0.2+0.2-0.2
Next day
+1.0+0.2+0.9-0.3+1.4
2d
-0.7-0.1-0.7-0.5-0.3
3d
-1.7-1.7+0.1-1.2-0.4
4d
-1.0-0.3-0.7-0.6-0.4
5d
+0.8+1.0-0.2-0.1+0.8
1w
+2.3+0.5+1.8+0.6+1.8
15d
+0.9-1.1+2.0-1.9+2.9
1m
+5.1+2.1+3.0-0.8+5.9
2m
+5.5+1.2+4.3+0.8+4.8
3m
+4.8-5.1+9.9+0.3+4.4
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CTL Trusteeship Ltd, acting as common security trustee for debenture holders, has disclosed creation of pledge over 66,32,651 equity shares (5.31%) of Ajanta Pharma Limited. Total encumbered shares including covenants stand at 1,69,12,924 shares (13.53%). The pledge was created by Aayush Agrawal Trust (38.32 lakh shares), Gabs Investments Pvt Ltd (27.70 lakh shares), and Aayush Agrawal (30,000 shares) to secure debentures of about Rs 3,373 crore from Lenexis Foodworks and Rs 500 crore from Inspira Realty 2, issued to CTL Trusteeship. Acquirer is not a promoter.

Likely market impact

New pledge creation by promoter group entities; 13.53% encumbrance is sizeable and may raise concerns about leverage, but no invocation reported.